500 results on '"Hui, David S. C."'
Search Results
2. Baseline gut microbiota and metabolome predict durable immunogenicity to SARS-CoV-2 vaccines
3. Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population
4. Author Correction: Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population
5. Cross‐Reactive Antibody Responses to Coronaviruses Elicited by SARS‐CoV‐2 Infection or Vaccination
6. Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination
7. Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome
8. Trajectory patterns of SARS-CoV-2 neutralising antibody response in convalescent COVID-19 patients
9. Priming conditions shape breadth of neutralizing antibody responses to sarbecoviruses
10. SARS-CoV-2 accessory proteins reveal distinct serological signatures in children
11. Early Metabolomic and Immunologic Biomarkers as Prognostic Indicators for COVID-19.
12. Temporal trends in rates of infection-related hospitalisations in Hong Kong people with and without diabetes, 2001–2016: a retrospective study
13. A 5‐year perspective on coronavirus diseases 2019 (COVID‐19).
14. Neutralizing antibody titres in SARS-CoV-2 infections
15. SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection
16. Impact of interprofessional service-learning on the effectiveness of knowledge transfer of antimicrobial resistance to Hong Kong elders: a quasi-experiment
17. Temporal landscape of human gut RNA and DNA virome in SARS-CoV-2 infection and severity
18. High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission
19. Inferring Incidence of Unreported SARS-CoV-2 Infections Using Seroprevalence of Open Reading Frame 8 Antigen, Hong Kong.
20. Author Correction: Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population
21. Characterization of upper airway microbiome across severity of COVID-19 during hospitalization and treatment
22. Use of point-of-care biomarkers to reduce antibiotic resistance
23. Obstructive Sleep Apnea, Obesity, and Noninvasive Ventilation: Considerations During the COVID-19 Pandemic
24. Pneumomediastinum and subcutaneous emphysema complicating a patient with a lung abscess
25. Noninvasive Ventilation in Patients with Severe Acute Respiratory Syndrome
26. Noninvasive Mechanical Ventilation: Models to Assess Air and Particle Dispersion
27. Serological Assays for Differentiating Natural COVID-19 Infection from Vaccine Induced Immunity
28. High Viral Load and Respiratory Failure in Adults Hospitalized for Respiratory Syncytial Virus Infections
29. Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments
30. Antiviral treatment and prophylaxis for influenza.
31. Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
32. Coronaviruses — drug discovery and therapeutic options
33. Contemporary Concise Review 2021: COVID ‐19 and other respiratory infections
34. Influenza B Lineage Circulation and Hospitalization Rates in a Subtropical City, Hong Kong, 2000–2010
35. Comprehensive care programme for patients with chronic obstructive pulmonary disease: a randomised controlled trial
36. Ocular surface disturbance in patients after acute COVID‐19
37. Complications and Outcomes of Pandemic 2009 Influenza A (H1N1) Virus Infection in Hospitalized Adults: How Do They Differ From Those in Seasonal Influenza?
38. Possible Role of Aerosol Transmission in a Hospital Outbreak of Influenza
39. Viral Loads and Duration of Viral Shedding in Adult Patients Hospitalized with Influenza
40. Impact of the Use of Oral Antiviral Agents on the Risk of Hospitalisation in Community COVID-19 Patients
41. Metformin Does Not Reduce Hospitalisation for COVID-19
42. Dysnatraemia During COVID-19 Diagnosis and Background Hyponatraemia are Associated with Adverse Clinical Outcomes of COVID-19
43. Plaque-Neutralizing Antibody to BA.2.12.1, BA.4 and BA.5 in Individuals with Three Doses of Biontech or Coronavac Vaccines, Natural Infection and Breakthrough Infection
44. Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19
45. Anti-Severe Acute Respiratory Syndrome Coronavirus Immune Responses: The Role Played by Vγ9Vδ2 T Cells
46. Factors Associated With Difference In Prevalence Of Asthma In Children From Three Cities In China: Multicentre Epidemiological Survey
47. A Randomized Controlled Study to Examine the Effect of a Lifestyle Modification Program in OSA
48. Using a portable monitoring device for diagnosing obstructive sleep apnea in patients with multiple coexisting medical illnesses
49. Antineoplastic effects of 15(S)-hydroxyeicosatetraenoic acid and 13-S-hydroxyoctadecadienoic acid in non–small cell lung cancer
50. How should aerosol generating procedures be defined?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.